Ocular Therapeutix, Inc. (OCUL)

Ocular Therapeutix Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Nov 4, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	1,601	492	216	534	1,559	190
Market Cap Growth	164.84%	127.16%	-59.47%	-65.74%	720.77%	15.59%
Enterprise Value	1,235	464	155	413	1,546	183
Last Close Price	10.39	4.46	2.81	6.97	20.70	3.95
PE Ratio	-	-4.39	-2.89	-7.13	-8.08	-2.07
PS Ratio	19.63	8.41	4.20	12.27	89.57	44.93
PB Ratio	4.28	5.39	6.12	6.07	20.48	-52.32
P/FCF Ratio	-11.69	-6.44	-3.42	-8.00	-28.66	-2.38
P/OCF Ratio	-11.92	-7.00	-3.63	-8.15	-29.11	-2.45
EV/Sales Ratio	20.22	7.94	3.01	9.50	88.85	43.26
EV/EBITDA Ratio	-5.88	-5.84	-2.03	-5.47	-25.74	-2.20
EV/EBIT Ratio	-5.69	-5.63	-1.97	-5.30	-24.60	-2.13
EV/FCF Ratio	-7.19	-6.08	-2.45	-6.19	-28.43	-2.29
Debt / Equity Ratio	0.20	0.92	1.82	0.67	0.77	-16.35
Debt / FCF Ratio	-0.83	-1.09	-1.02	-0.88	-1.07	-0.74
Asset Turnover	0.19	0.29	0.29	0.19	0.10	0.06
Inventory Turnover	36.37	31.01	35.98	44.46	28.56	74.15
Quick Ratio	16.35	6.36	3.94	7.04	9.01	4.74
Current Ratio	16.64	6.66	4.13	7.26	9.23	5.00
Return on Equity (ROE)	-72.67%	-127.64%	-115.16%	-7.99%	-429.55%	-535.72%
Return on Assets (ROA)	-22.37%	-25.66%	-27.76%	-20.90%	-23.06%	-70.66%
Return on Capital (ROIC)	-27.49%	-37.56%	-39.86%	-34.65%	-41.29%	-92.16%
Earnings Yield	-8.54%	-16.42%	-32.83%	-1.23%	-9.98%	-45.48%
FCF Yield	-5.59%	-15.53%	-29.26%	-12.50%	-3.49%	-42.03%
Buyback Yield / Dilution	-49.22%	-3.57%	-0.59%	-35.24%	-34.19%	-18.78%
Total Shareholder Return	-49.22%	-3.57%	-0.59%	-35.24%	-34.19%	-18.78%

Source: S&P Capital IQ. Standard template. Financial Sources.